Synergy Advisors Research
Advisory Approach
Synergy Advisors is a boutique investment bank founded in 2003 and headquartered in El Segundo, California, specializing in providing senior banker-led advisory services to healthcare and regional middle-market companies. The firm operates with a clear thesis: best-in-class advisory requires senior-level attention throughout the transaction process, with experienced bankers who understand the nuances of their clients' industries and can navigate complex deal dynamics with creativity and rigor.
The Synergy approach differentiates itself through sustained principal involvement. Rather than assigning junior bankers with senior oversight, Synergy ensures that Managing Partners and Managing Directors work directly with clients from engagement through close. This philosophy has proven effective across hundreds of transactions, with the firm having completed over 300 transactions with aggregate enterprise value exceeding $50 billion.
The firm was founded by Robert Morgan Maggiacomo, who previously led West Coast Healthcare Investment Banking at Bear Stearns (1998-2001). Maggiacomo built Synergy with co-founder James Albert Emslie and Managing Director Scott Messier, creating a practice rooted in decades of Wall Street investment banking experience applied to underserved middle-market and healthcare clients.
Sector Focus
Synergy's primary focus is healthcare services, where the firm has deep expertise across multiple segments. The healthcare practice specializes in:
Healthcare Providers & Services: Physician practice management (PPM), acute care hospitals, post-acute care facilities (home health, hospice, skilled nursing, rehabilitation, long-term acute care), specialty hospital services, and diagnostic services (imaging centers, laboratory testing). The firm has particular expertise in Medicaid-dependent healthcare businesses and payor-provider integration models.
Healthcare Payors: Managed care organizations (Medicaid managed care, Medicare Advantage, commercial managed care, specialty managed care in dental, vision, and behavioral health), pharmacy benefit management (PBM), and risk adjustment analytics platforms. The firm maintains active dialogue on both buy-side and sell-side for payor clients.
Healthcare Technology & IT: The firm advises healthcare IT companies including care management software, population health platforms, provider credentialing systems, and pharmacy analytics platforms. This segment has grown significantly as healthcare delivery models shift toward value-based and technology-enabled care.
Specialty Healthcare: Medical devices, orthopedics, dental services, veterinary services, and pharmaceutical distribution to institutional and specialty pharmacy channels.
Beyond healthcare, Synergy maintains an active regional middle-market practice advising companies in consumer & retail, industrial products & services, distribution & logistics, and business services sectors. The firm focuses on family-owned and founder-operated companies seeking liquidity events or growth capital in the $15M-$500M transaction range.
Deal Track Record
Synergy has completed a diverse transaction history across healthcare and middle-market sectors:
Dental Services: Successfully advised Kids Dental Kare, one of California's largest pediatric dental providers with 14 clinics serving 75,000+ children annually (primarily Denti-Cal/Medicaid), on its sale to Western Dental. The transaction achieved valuations double the founder's initial expectations and involved identifying and recruiting specialized interim CFO support and Medicaid consulting resources to maximize buyer confidence.
Healthcare Pathology & Diagnostics: Advised AD PathLabs, a growth-stage anatomical pathology and esoteric testing company, on an exclusive sale process. When initial buyer reception was tepid due to perceived business model risk, Synergy secured bridge financing to sustain the company and identified a second cohort of strategic buyers, ultimately closing with physician-led Pathology, Inc., who viewed AD PathLabs' business model as complementary to their own operations.
Healthcare Services & Operations: Advised Health Information Designs (healthcare IT services) on a transaction and served as financial advisor to Kepro on its acquisition of eQHealth in 2021. Also served as exclusive financial advisor to Devlin Consulting on its acquisition by Sagility in April 2023.
Imaging & Diagnostics: Advised Consensys Imaging Service on a merger integration with MXR and worked with clients in medical equipment services including Radiographic Equipment Services.
Vision & Specialty Consumer: Advised Kaenon Polarized, a producer of polarized eyewear, on securing strategic growth capital while maintaining founder control through structured partnership with a larger strategic investor.
Software & IT: Advised System Dynamics, a closely-held software business, on a sale to a Fortune 500 company on an accelerated timeline driven by tax considerations.
Specialty Hospitals: Worked extensively with Trillium Specialty Hospital and other specialty acute care providers on strategic transactions.
Managed Care & Payor Services: Maintains a multi-decade relationship with Molina Healthcare, a Fortune 500 managed care company, advising on corporate development, acquisitions, and divestitures. CFO John Molina has characterized Synergy's advisory capabilities as equivalent to top-tier Wall Street firms.
Process & Fee Structure
Synergy employs institutional-quality M&A processes tailored to client circumstances. The firm typically runs exhaustive buyer outreach processes for sell-side mandates, identifying and targeting 60-200+ strategic and financial buyers depending on the business profile. The process includes comprehensive quality of earnings (QofE) support, management presentation coaching, structured data room preparation, and rigorous negotiation and structuring guidance.
For private capital financings, Synergy leverages corporate finance expertise to optimize capital structure, identify institutional sources (PE firms, venture capital, mezzanine providers, and banks), and execute private placements of debt, equity, and hybrid instruments.
While fee information is not explicitly published, the firm's market focus of $15-$500M in M&A and $10M+ in private capital raising, combined with boutique positioning, suggests compensation in line with regional middle-market advisors: modified Lehman formulas or flat percentages negotiable based on engagement complexity and size. The firm requires senior banker engagement and focuses on deal outcomes rather than transaction velocity.
Buyer Network & Strategic Positioning
Synergy maintains relationships with thousands of potential acquirers and capital sources, including:
Strategic Acquirers: Fortune 500 healthcare operators, mid-market healthcare roll-ups, regional hospital networks, managed care companies, pharmacy benefit managers, and vertical integrators across healthcare.
Financial Sponsors: Private equity firms active in healthcare, middle-market buyout funds, growth equity providers, and family offices.
Healthcare-Specific Buyers: PE-backed roll-ups in dental services (Western Dental), imaging services (MXR), pathology (Pathology, Inc.), and IT services.
The firm's buyer network strength is particularly deep in healthcare services, where years of advisory work have created natural introductions and understanding of buyer investment thesis and strategic priorities.
Competitive Positioning
Synergy differentiates from competitors through:
-
Senior Banker Continuity: Unlike larger banks that assign junior bankers, Synergy ensures managing partners/directors work directly with clients, bringing decades of experience and judgment rather than just execution.
-
Healthcare Deep Expertise: The founding team has specialized in healthcare investment banking since the 1990s, giving the firm and its bankers institutional knowledge of specific segments, regulatory dynamics, buyer preferences, and value drivers across healthcare.
-
Regional Relationship Density: Based in Southern California with licensed coverage across 12 states, Synergy has built relationship density in regional markets that national firms cannot match.
-
Creative Problem-Solving: As evidenced by the AD PathLabs case (bridging capital arranged when buyer reception was weak) and the Kaenon transaction (maintaining founder control in growth capital structures), the firm approaches obstacles with pragmatism rather than template solutions.
-
Size-Appropriate Attention: Synergy's positioning allows mid-market clients (especially healthcare) to access the quality of bankers that billion-dollar companies receive, without the bureaucracy or conflicts of larger institutions.
Not a Fit If
Synergy typically declines:
- Transactions below the $15M M&A / $10M capital raising thresholds
- Businesses requiring minimal buyer outreach or limited process
- Non-healthcare, non-middle-market businesses outside their geographic focus
- Situations requiring highly specialized industry expertise beyond healthcare and regional services
Team
The firm employs senior bankers with extensive Wall Street and investment banking experience:
Robert Morgan Maggiacomo (CEO, Managing Partner): 24+ years as Managing Partner/Founder of Synergy (since 2003). Previously spent 3 years as Managing Director and Head of West Coast Healthcare Investment Banking at Bear Stearns (1998-2001). Registered Principal with FINRA (Series 79, 63, 65 licenses across multiple states). Holds over 31 years of investment banking and securities industry experience.
James Albert Emslie (Partner, Member): Co-founder alongside Maggiacomo. Registered Principal with FINRA. Serves as AML Officer. Deep expertise in healthcare payor and provider transactions.
Scott Messier (Managing Director): Banking executive with focus on managed care and healthcare payor advisory.
Timothy Ome (Senior Advisor): Senior-level contributor to transaction teams.
Scott Quigley (Managing Director): Registered Principal with FINRA (Series 79 and 63 licenses).
All senior bankers have held leadership roles at major Wall Street firms and bring institutional knowledge to transactions.
Regulatory & Legal Standing
Synergy Advisors, LLC is a FINRA-registered broker-dealer (CRD# 128264 / SEC# 8-66114) established as a Delaware limited liability company on July 31, 2003. The firm is licensed to conduct securities business in 12 states (AL, AZ, CA, CO, IL, KY, MA, NJ, NY, PA, TX, WA) and carries FINRA and SIPC membership. The firm maintains zero disclosed regulatory issues or customer complaints on BrokerCheck.
Geographic Coverage
Headquartered in El Segundo (Los Angeles), California with licensed operations across the Western and Central United States. Primary markets include California, Arizona, Colorado, Texas, and the broader Southwest and Midwest. International capability limited but relationships exist with cross-border healthcare and strategic buyers.
Thesis & Investment Approach
Synergy believes that middle-market and healthcare companies traditionally underserved by large investment banks deserve access to senior-level, experienced judgment and execution. The firm's approach combines investment banking rigor with boutique flexibility, allowing the firm and its clients to pursue creative solutions that large institutions cannot or will not consider. By staying focused on healthcare and regional middle-market, the firm maintains deep expertise and relationship density rather than spreading capabilities across multiple industries.